Tempus soars 15% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI

Date:

Share post:


Tempus, a genomic testing and data analysis company started by Eric Lefkosky, who previously founded Groupon, debuted on Nasdaq on Friday, rose about 15% on the opening 

The company priced its IPO on Thursday at $37 apiece, at the top of its $35 to $37 price range, raising nearly $411 million at a fully-diluted valuation of over $6 billion. Tempus’ last official private valuation was $8.1 billion, however, and PitchBook data, estimates that the company was valued at $10.25 billion in late 2022.

Despite the substantial discount from its previous valuation, the IPO is a feat for an unprofitable company during a time that’s considered to be a lukewarm time to launch public offerings. Tempus’ revenues were $531 million in 2023 with a net loss of $290 million. But the company’s operating losses have shrunk from 83% in 2022 to 37% in 2023, and Lefkosky told CNBC that he expects Tempus to be cash flow and EBITDA positive in 2025.

Lefkofsky founded Tempus in 2015, after noticing that doctors didn’t rely on data during his wife’s treatment of breast cancer. He set out to build a company that uses technology and data derived from genomic sequencing.

Tempus is now trying to position itself as an AI company, even though AI revenue accounted for only $5.5 million of revenue, approximately 1% of its 2023 revenue. The company said in its prospectus that its AI product line is nascent, but it intends “to embed AI, including generative AI” in every aspect of its diagnostics tools.

Lefkofsky is by far the largest shareholder in the company. According to the S1, he holds 30.1% of the company and 65% of shareholder voting power, due to the dual-class share structure. The firm controlled by Kimberley Keywell, the former wife of Brad Keywell, Lefkosfky’s longtime business partner, owns a 10.2% stake in Tempus. Scottish asset manager Baillie Gifford, holds 5.9% of the company, worth $350 million at the IPO price.

Early shareholders in Tempus include NEA, Revolution and T. Rowe Price. The company raised a $200 million Series G5 from SoftBank in April.Tempus is the fourth company Lefkofsky is taking public. He is most known for having founded Groupon, which went public at a valuation of nearly $13 billion in 2011, but now trades at under $600 million.

Tempus is the fourth company Lefkofsky is taking public. He is most known for having founded Groupon, which went public at a valuation of nearly $13 billion in 2011, but now trades at under $600 million.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

Former basketball hopeful wants to prevent ACL tears with airbags for knees

You’ve heard of car airbags deploying within milliseconds to protect passengers. How about an airbag for your...

Indian news agency sues OpenAI alleging copyright infringement

One of India’s largest news agencies, Asian News International, has sued OpenAI in a case that could...

Sagence is building analog chips to run AI

Graphics processing units (GPUs), the chips on which most AI models run, are energy-hungry beasts. As a...

Yuka, the app that rates food and makeup, now lets users complain to companies directly

Yuka is a popular health app that allows users to scan the barcodes of food items to...

Socium doubles down on Francophone Africa after $5M seed round

Demand for HR-tech solutions in Africa is growing, and Senegal’s Socium is out to tap the opportunity...

Logitech’s MX console for creatives

Deep into Adobe apps like Photoshop or Premiere? Logitech’s MX Creative Console is designed to streamline your...

Ben Affleck tells actors and writers not to worry about AI

Unions representing Hollywood actors and writers went on strike last year to secure protections against AI systems...

Venture funding in Europe in 2024 fell to $45 billion, says Atomico

Funding for European tech appears to have stabilized in 2024 after dropping precipitously in 2023, but the...